July 1, 2026
HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
B Industry veteran brings 25+ years of global clinical leadership from Ferring, Novartis, NIBR, Bayer, and SixPeaks Bio to support HERVolution’s cardiometabolic pipeline Tankó’s strategic…
